Laparoscopic gastric cancer surgery: Current evidence and future perspectives

World J Gastroenterol. 2016 Jan 14;22(2):727-35. doi: 10.3748/wjg.v22.i2.727.

Abstract

Laparoscopic gastrectomy has been widely accepted as a standard alternative for the treatment of early-stage gastric adenocarcinoma because of its favorable short-term outcomes. Although controversies exist, such as establishing clear indications, proper preoperative staging, and oncologic safety, experienced surgeons and institutions have applied this approach, along with various types of function-preserving surgery, for the treatment of advanced gastric cancer. With technical advancement and the advent of state-of-the-art instruments, indications for laparoscopic gastrectomy are expected to expand as far as locally advanced gastric cancer. Laparoscopic gastrectomy appears to be promising; however, scientific evidence necessary to generalize this approach to a standard treatment for all relevant patients and care providers remains to be gathered. Several multicenter, prospective randomized trials in high-incidence countries are ongoing, and results from these trials will highlight the short- and long-term outcomes of the approach. In this review, we describe up-to-date findings and critical issues regarding laparoscopic gastrectomy for gastric cancer.

Keywords: Advanced gastric cancer; Early gastric cancer; Gastrectomy; Laparoscopic resection; Minimally invasive surgery; Stomach neoplasms.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Adenocarcinoma / pathology
  • Adenocarcinoma / surgery*
  • Diffusion of Innovation
  • Evidence-Based Medicine
  • Forecasting
  • Gastrectomy / adverse effects
  • Gastrectomy / methods*
  • Gastrectomy / trends
  • Humans
  • Laparoscopy* / adverse effects
  • Laparoscopy* / trends
  • Postoperative Complications / etiology
  • Stomach Neoplasms / pathology
  • Stomach Neoplasms / surgery*
  • Treatment Outcome